Real Power Capital
Overview
Real Power Capital is a venture capital firm founded in 2015. The firm focuses on investments in the technology and healthcare industries.
Portfolio Companies
7
Website
realpowercapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Everest Medicines | Jun 2020 | Series C | Co-investor |
| Abogen Biosciences | Aug 2021 | Series C | Co-investor |
| Transwarp | Feb 2016 | Series B | Lead |
| Yantai Lannacheng Biotechnology Co., Ltd. | Jul 2025 | Series C | Co-investor |
| Shanghai Bondent Technology Co., Ltd. | Sep 2017 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Real Power Capital based?
Real Power Capital is headquartered in Shanghai, Shanghai, China.
When was Real Power Capital founded?
Founding year information for Real Power Capital is not publicly available.
How many portfolio companies does Real Power Capital have?
Real Power Capital has 7 portfolio companies in Caplight's dataset.
What are some companies in Real Power Capital's portfolio?
Portfolio companies visible on Caplight include Everest Medicines, Abogen Biosciences, Transwarp, Yantai Lannacheng Biotechnology Co., Ltd., Shanghai Bondent Technology Co., Ltd..
What was Real Power Capital's most recent investment shown here?
Real Power Capital's most recent investment in this portfolio sample was in Yantai Lannacheng Biotechnology Co., Ltd. in 2025.
What sectors does Real Power Capital focus on?
Real Power Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Energy & Sustainability.
What company stages does Real Power Capital focus on?
Real Power Capital typically invests at the Mid stage.
What is Real Power Capital's AUM?
Real Power Capital's assets under management are estimated between $1.8B and $1.8B.